WallStSmart
PRE

Prenetics Global Ltd

NASDAQ: PRE · HEALTHCARE · DIAGNOSTICS & RESEARCH

$16.71
-4.02% today

Updated 2026-04-30

Market cap
$310.15M
P/E ratio
P/S ratio
3.36x
EPS (TTM)
$-3.79
Dividend yield
52W range
$5 – $24
Volume
0.2M

Prenetics Global Ltd (PRE) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20032004200520062007200820092010201120122013201420152019202020212022202320242025
Operating cash flow$1.15B$1.26B$1.03B$491.77M$1.23B$1.16B$1.10B$1.23B$573.63M$693.29M$827.27M$852.60M$318.81M$-1.88M$-2.88M$13.42M$14.51M$-13.76M$-28.87M$-21.81M
Capital expenditures$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$373858.00$3.06M$11.41M$6.34M$911813.00$1.06M$208000.00
Depreciation
Stock-based comp$3.91M$1.62M$22.49M$31.58M$10.59M$11.98M
Free cash flow$1.15B$1.26B$1.03B$491.77M$1.23B$1.16B$1.10B$1.23B$573.63M$693.29M$827.27M$852.60M$318.81M$-2.26M$-5.94M$2.00M$8.17M$-14.68M$-29.94M$-22.02M
Investing cash flow
Financing cash flow
Dividends paid$93.42M$92.27M$118.92M$125.42M$130.93M$134.63M$151.85M$192.16M$205.78M$217.62M$200.08M$190.96M$190.34M$0.00$0.00$0.00$0.00$0.00$0.00
Share repurchases
Debt repayment
Net change in cash